Esperion Therapeutics Statistics
Total Valuation
ESPR has a market cap or net worth of $392.45 million. The enterprise value is $472.28 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ESPR has 196.22 million shares outstanding. The number of shares has increased by 76.93% in one year.
Shares Outstanding | 196.22M |
Shares Change (YoY) | +76.93% |
Shares Change (QoQ) | -0.45% |
Owned by Insiders (%) | 0.72% |
Owned by Institutions (%) | 68.87% |
Float | 194.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.05 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.70 |
EV / EBITDA | 94.65 |
EV / EBIT | 95.45 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.97
Current Ratio | 1.97 |
Quick Ratio | 1.42 |
Debt / Equity | n/a |
Debt / EBITDA | 46.08 |
Debt / FCF | n/a |
Interest Coverage | 0.09 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 1.05% |
Return on Capital (ROIC) | 8.16% |
Revenue Per Employee | $1.16M |
Profits Per Employee | -$410,404 |
Employee Count | 240 |
Asset Turnover | 0.95 |
Inventory Turnover | 1.66 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +94.18% in the last 52 weeks. The beta is 0.95, so ESPR's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | +94.18% |
50-Day Moving Average | 1.88 |
200-Day Moving Average | 2.21 |
Relative Strength Index (RSI) | 49.56 |
Average Volume (20 Days) | 2,752,555 |
Short Selling Information
The latest short interest is 35.39 million, so 18.03% of the outstanding shares have been sold short.
Short Interest | 35.39M |
Short Previous Month | 37.47M |
Short % of Shares Out | 18.03% |
Short % of Float | 18.16% |
Short Ratio (days to cover) | 10.64 |
Income Statement
In the last 12 months, ESPR had revenue of $277.79 million and -$98.50 million in losses. Loss per share was -$0.68.
Revenue | 277.79M |
Gross Profit | 169.78M |
Operating Income | 4.95M |
Pretax Income | -98.50M |
Net Income | -98.50M |
EBITDA | 4.99M |
EBIT | 4.95M |
Loss Per Share | -$0.68 |
Full Income Statement Balance Sheet
The company has $189.30 million in cash and $269.14 million in debt, giving a net cash position of -$79.83 million or -$0.41 per share.
Cash & Cash Equivalents | 189.30M |
Total Debt | 269.14M |
Net Cash | -79.83M |
Net Cash Per Share | -$0.41 |
Equity (Book Value) | -344.22M |
Book Value Per Share | -1.77 |
Working Capital | 169.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$9.76 million and capital expenditures -$150,000, giving a free cash flow of -$9.91 million.
Operating Cash Flow | -9.76M |
Capital Expenditures | -150,000 |
Free Cash Flow | -9.91M |
FCF Per Share | -$0.05 |
Full Cash Flow Statement Margins
Gross margin is 61.12%, with operating and profit margins of 1.78% and -35.46%.
Gross Margin | 61.12% |
Operating Margin | 1.78% |
Pretax Margin | -35.46% |
Profit Margin | -35.46% |
EBITDA Margin | 1.80% |
EBIT Margin | 1.78% |
FCF Margin | -3.57% |
Dividends & Yields
ESPR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -76.93% |
Shareholder Yield | -76.93% |
Earnings Yield | -25.10% |
FCF Yield | -2.52% |
Analyst Forecast
The average price target for ESPR is $8.17, which is 308.50% higher than the current price. The consensus rating is "Buy".
Price Target | $8.17 |
Price Target Difference | 308.50% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 63.73% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
ESPR has an Altman Z-Score of -4.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.5 |
Piotroski F-Score | 5 |